Full of Calories, Starving One Cell Deep | The Angry Gut, Chapter 14

Butyrate deficiency symptoms · Stool test

Butyrate Deficiency Symptoms and What a Stool Test Really Shows

Butyrate deficiency has no symptom list of its own: loose stools, bloating, urgency and fatigue belong to twenty conditions. A low stool butyrate mostly samples the 5% of short-chain fatty acids your colon did not absorb.

A stool panel flags butyrate low and the bottle is in the cart before anyone asks what the number sampled. It sampled the remainder after your colon ate.

Butyrate deficiency symptoms is a phrase built on a test result rather than on a disease. Low butyrate gets flagged on mail-order stool panels, and the panels are sold as though the number described the state of your colon. What it mostly describes is the small share your colon did not absorb.

The video Full of Calories, Starving One Cell Deep follows a man of fifty-eight who tracked three thousand calories a day and still had a bowel lining running short of fuel. It belongs to The Angry Gut, by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes. Measura [Cardiometabolic and Autonomic Health Analysis] is a testing service, and stool or short-chain fatty acid panels are not in its library, so the useful question becomes what can be measured in the same person.

What is butyrate, and what makes it?

Butyrate is a short-chain fatty acid, and it is the fuel the lining of the large bowel prefers to burn. Your own cells cannot build it. Bacteria ferment the fiber you cannot digest and hand it over, or the fuel never exists at all. Each day a human colon ferments somewhere between 400 and 600 mmol of these acids, roughly 60:20:20 across acetate, propionate and butyrate.

Demand never pauses. Pooled across 85 studies and 265 people, the cells lining the human gut are replaced about every 3.48 days, so the delivery has to keep arriving. In the language of the book, the gut is the first brain and the organ in your skull is the second brain, and the first brain is the one that meets every meal before anything else does.

What are the symptoms of butyrate deficiency?

Loose stools, bloating, urgency and fatigue belong to twenty conditions, which is why no symptom marks a starved lining. The man in the video had four years of loose stools, a colonoscopy read as normal, and biopsies described as mild nonspecific changes. None of that is a diagnosis. It is a supply problem, and a supply problem announces itself vaguely or not at all.

What does a low butyrate stool test mean?

Here is the rule worth carrying past any panel. Of the short-chain fatty acids made in the colon, 95% are absorbed by the cells that line it, and the 5% that leaves in stool is what a laboratory samples. When those acids are labeled and delivered straight to a human colon, the share turning up in the bloodstream is 2% for butyrate, against 9% for propionate and 36% for acetate. Butyrate is consumed on site.

So a fecal concentration is residue, not production. A low value can equally mean a colon that absorbed well. Dr. Padda repeated the familiar line that butyrate supplies 70% of the colon cell’s energy for years before he opened the 1980 experiment behind it: suspensions of human colon cells from 14 operative specimens, where butyrate accounted for 73% of oxygen consumption in the ascending colon and 75% in the descending, falling to 59% and 72% once ordinary glucose was in the dish as well. He had the unit wrong. It is a share of oxygen used in a dish, never a share of the energy inside a living person, and nobody has measured that inside one.

Can daily medications like omeprazole change gut bacteria?

Two drugs in that man’s morning routine mattered more than anything on his plate. He had taken omeprazole daily since 2015. Across 1,815 people, 211 of them on a proton pump inhibitor, the drug came with lower bacterial diversity and shifts in 20% of bacterial groups, an effect the investigators judged more prominent at population level than antibiotics. Add an acid blocker to a daily anti-inflammatory and the small bowel pays: injury appeared in 44.4% of volunteers against 16.7% without it.

Nobody prescribed that pairing as a plan. It assembled itself out of single reasonable refills, because a renewal takes a minute and a real review takes an appointment that never gets scheduled. Meanwhile the food system subsidizes the calories that feed you and sells capsules for the bacteria those same calories starved. That is the third driver in this story, and it is not biological.

What Measura can measure in the same person

None of the following watches your bacteria work. What they do is describe the metabolic ground your gut is sitting in, which is the part that connects to metaflammation, the low-grade inflammation running underneath insulin resistance and chronic pain.

Indirect calorimetry measures resting energy use from the air you breathe rather than estimating it from height and weight.
Bioimpedance body composition separates fat from muscle and water, which a bathroom scale cannot do at any price point.
Laboratory panels put current numbers behind blood sugar, lipids and inflammatory markers.

Stool testing, breath testing and colonoscopy are different studies, ordered and performed elsewhere. Measura measures; the findings go to the physician who treats you, and the decisions stay there. When every result so far has read normal, the point of measuring is not reassurance. It is putting a current number on the things nobody has actually measured yet.

What to ask before buying another panel

Ask any panel what it sampled. If the answer is stool, you are reading the remainder after absorption.
Ask why a daily acid blocker is still on your list, when the reason was last examined, and whether an anti-inflammatory is going down beside it. That is a conversation for your prescriber, never a change you make alone.
Count the separate plant foods on your last three days rather than the milligrams on a bottle. Higher fiber intake carried a 15-30% decrease in all-cause and cardiovascular mortality, with the benefit greatest between 25 g and 29 g a day.
Expect gas as fiber rises. Pooled constipation trials, 16 of them with 1,251 adults, found response in 66% given fiber and 41% given control; psyllium and pectin above 10 g a day did that work, and flatulence worsened more than stool consistency improved. Early bloating is expected physiology.

Every study behind the argument, with the numbers it does and does not support, is in the book’s Deep Dive companion. The story continues with the additives that land on the layer this fuel protects, in what no test can tell you about emulsifiers.

Frequently asked questions

Is a low butyrate number on a stool panel a real deficiency?

Less than the report implies. Roughly 95% of what your colon produces is absorbed on the spot, so a stool value samples the leftover 5%, and only 2% of butyrate delivered to a human colon ever reaches the blood. Read the result as a prompt to look at what you eat, not as a deficiency with a dose attached. What a test result can and cannot tell you.

Does Measura test stool, breath or the microbiome?

No. The library covers vascular, autonomic, nerve, metabolic, body composition, balance and cognitive measurements. Anything sampling stool or breath, and anything involving a scope, is a separate study your physician orders elsewhere. Bringing both kinds of result to one appointment is usually more useful than adding another panel. What Measura actually measures.

Will a butyrate capsule fix a starved colon?

The arithmetic argues against it. Only 2% of butyrate arriving in a human colon gets into the circulation, a month of 4 g a day in 30 adults with longstanding type 1 diabetes raised the stool number and moved nothing else, and enema trials pooled across 227 patients showed no clinical difference. Fiber carries the evidence a capsule does not. Insulin resistance and metabolic health.

My colonoscopy was normal. Why do I still feel unwell?

A scope looks for disease, and it is very good at that. It does not measure fuel supply, resting energy use or how much of your weight is muscle. Biopsies reported as mild nonspecific changes describe tissue that is not well and not diseased, which is exactly the gap a metabolic measurement is for. Understanding your results.

How is a testing plan put together for symptoms like these?

It starts from what you are describing and what has already been ruled out, then picks measurements that answer a question nobody has answered yet, such as resting metabolic rate or the fat and muscle split behind a stable weight. Findings are reported to your physician, who decides what changes. How a testing plan is chosen.

How do I know if I need butyrate?

No symptom and no stool number answers that on its own. Loose stools, bloating, urgency and fatigue belong to twenty conditions, and a stool panel samples only the 5% your colon did not absorb. Better questions: how many separate plant foods did you eat in the last three days, why is a daily acid blocker still on your list, and what do your metabolic measurements show?

What food has the most butyrate?

The butyrate your colon lining runs on is made on site. Your own cells cannot build it; bacteria ferment the fiber you cannot digest and hand it over. So the useful target is fiber, not a butyrate food or capsule. Higher fiber intake carried a 15-30% decrease in all-cause and cardiovascular mortality, with the greatest benefit between 25 g and 29 g a day.

What are the symptoms of bad bacteria in the gut?

The symptoms people describe, such as loose stools, bloating, urgency and fatigue, belong to twenty conditions, so none of them points to one cause. Medications are worth checking first: daily proton pump inhibitor use came with lower bacterial diversity and shifts in 20% of bacterial groups. Any change to a prescription is a conversation with your prescriber, never a change you make alone.

Put current numbers behind the symptoms

If your bowel symptoms have outlasted a normal workup, ask about Measura metabolic, body composition and laboratory testing, with the findings sent to your own physician.

Send a message

4477 Woodson Rd, Suite 201, St. Louis, MO 63134. Monday to Friday, 9:00 a.m. to 5:00 p.m. Please do not send symptoms, diagnoses or images through a web form — a website form is not a secure medical channel. Send your name and number and we will call you back.

References

den Besten, G., van Eunen, K., Groen, A. K., Venema, K., Reijngoud, D.-J., & Bakker, B. M. (2013). The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. Journal of Lipid Research, 54(9), 2325-2340. https://doi.org/10.1194/jlr.R036012
Boets, E., Gomand, S. V., Deroover, L., Preston, T., Vermeulen, K., De Preter, V., Hamer, H. M., Van den Mooter, G., De Vuyst, L., Courtin, C. M., Annaert, P., Delcour, J. A., & Verbeke, K. A. (2017). Systemic availability and metabolism of colonic-derived short-chain fatty acids in healthy subjects: a stable isotope study. The Journal of physiology, 595(2), 541-555. https://doi.org/10.1113/JP272613
Roediger, W. E. (1980a). Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut, 21(9), 793-798. https://doi.org/10.1136/gut.21.9.793
Darwich, A. S., Aslam, U., Ashcroft, D. M., & Rostami-Hodjegan, A. (2014). Meta-analysis of the turnover of intestinal epithelia in preclinical animal species and humans. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 42(12), 2016-2022. https://doi.org/10.1124/dmd.114.058404
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J., Dijkstra, G., Franke, L., Xavier, R. J., Jonkers, D., Wijmenga, C., Weersma, R. K., & Zhernakova, A. (2016). Proton pump inhibitors affect the gut microbiome. Gut, 65(5), 740-8. https://doi.org/10.1136/gutjnl-2015-310376
Washio, E., Esaki, M., Maehata, Y., Miyazaki, M., Kobayashi, H., Ishikawa, H., Kitazono, T., & Matsumoto, T. (2016). Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury: A randomized, placebo-controlled trial. Clinical gastroenterology and hepatology, 14(6), 809-815.e1. https://doi.org/10.1016/j.cgh.2015.10.022
Reynolds, A., Mann, J., Cummings, J., Winter, N., Mete, E., & Te Morenga, L. (2019). Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet (London, England), 393(10170), 434-445. https://doi.org/10.1016/S0140-6736(18)31809-9
van der Schoot, A., Drysdale, C., Whelan, K., & Dimidi, E. (2022). The effect of fiber supplementation on chronic constipation in adults: An updated systematic review and meta-analysis of randomized controlled trials. The American journal of clinical nutrition, 116(4), 953-969. https://doi.org/10.1093/ajcn/nqac184
de Groot, P. F., Nikolic, T., Imangaliyev, S., Bekkering, S., Duinkerken, G., Keij, F. M., Herrema, H., Winkelmeijer, M., Kroon, J., Levin, E., Hutten, B., Kemper, E. M., Simsek, S., Levels, J. H. M., van Hoorn, F. A., Bindraban, R., Berkvens, A., Dallinga-Thie, G. M., Davids, M., … Nieuwdorp, M. (2020). Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial. Diabetologia, 63(3), 597-610. https://doi.org/10.1007/s00125-019-05073-8
Jamka, M., Kokot, M., Kaczmarek, N., Bermagambetova, S., Nowak, J. K., & Walkowiak, J. (2021). The effect of sodium butyrate enemas compared with placebo on disease activity, endoscopic scores, and histological and inflammatory parameters in inflammatory bowel diseases: A systematic review of randomised controlled trials. Complementary medicine research, 28(4), 344-356. https://doi.org/10.1159/000512952